Codexis (CDXS) Pops, Gets FDA Approval for New Stagliptin Manufacturing Process
Go back to Codexis (CDXS) Pops, Gets FDA Approval for New Stagliptin Manufacturing Process| CODEXIS (NASDAQ: CDXS) | Delayed: 1.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.67 | 52 Week High | $5.25 | |||
| Open | $1.67 | 52 Week Low | $2.93 | |||
| Day High | $1.67 | P/E | N/A | |||
| Day Low | $1.67 | EPS | $-1.25 | |||
| Volume | 91 | |||||
